An intensified manufacturing process developed to support a trial of an Ebola vaccine in Uganda could help accelerate the production of other jabs in future health emergencies, according to Italian ...
ReiThera and Exothera entered into a collaboration agreement to develop a large-scale, low cost per dose manufacturing process for the production of ReiThera’s novel vaccines. The collaboration will ...
- Focus on developing a scale-up manufacturing process for the production of ReiThera's vaccine candidates based on its GRAd platform, including its COVID-19 vaccine candidate (GRAd-COV2) - Scale-up ...
An examination of the COVID-related transition to biotechnology platform-based techniques for vaccine development concludes that such smart manufacturing techniques could in the future be applied to ...
Scientists developed the COVID-19 vaccine lightning fast compared to typical vaccine timelines, thanks to decades of previous scientific work and monumental resources. But getting the vaccine through ...
NANTES, France--(BUSINESS WIRE)--Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of virus-based products, ...
The MVA platform is uniquely designed to incorporate multiple antigens into a single vaccine. This versatility allows GeoVax to develop vaccines targeting multiple aspects of a single pathogen or ...
Despite increased funding towards malaria research and vaccine development, the number of deaths from the parasitic disease returned over the past three years to the high numbers seen in 2012, with ...
GeoVax Advanced MVA Manufacturing Process: Aimed to Enhance Vaccine Supply Worldwide 27.01.2025 / 15:04 CET/CEST The issuer is solely responsible for the content of this announcement. Process Expected ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback